Back
Sera Prognostics 10K Form
Sell
36
SERA
Sera Prognostics
Last Price:
8.78
Seasonality Move:
164.64%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SERA News And Ratings
See the #1 stock for the next 7 days that we like better than SERA
SERA Financial Statistics
Sales & Book Value
| Annual Sales: | $306K |
|---|---|
| Cash Flow: | $-7.32M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.62 |
| Price / Book: | 5.08 |
Profitability
| EPS (TTM): | -0.99000 |
|---|---|
| Net Income (TTM): | $-32.24M |
| Gross Margin: | $96K |
| Return on Equity: | -49.65% |
| Return on Assets: | -36.7% |
Sera Prognostics Earnings Forecast
Key Sera Prognostics Financial Ratios
- The Gross Profit Margin over the past 5 years for SERA is 31.37%.
- The Selling, General & Administrative Expenses for SERA have been equal to 8,069.28% of Gross Profit Margin.
- The Research & Development expenses have been 4,975.49% of Revenue.
- The Interest Expense is -0.15% of Operating Income.
- The Net Earning history of SERA is -11,843.79% of Total Revenues.
- Per Share Earnings over the last 5 years have been positive in 1 years.
Sera Prognostics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | SERA |
| Website: | seraprognostics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 2.11 |
| Quick Ratio: | 2.06 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SERA Technical Analysis vs Fundamental Analysis
Sell
36
Sera Prognostics (SERA)
is a Sell
Is Sera Prognostics a Buy or a Sell?
-
Sera Prognostics stock is rated a Sell
The current Sera Prognostics [SERA] share price is $8.76. The Score for SERA is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.